Portal de Periódicos da CAPES

Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N ‐methyl( R )salsolinol, leading to apoptosis in SH‐SY5Y cells

2005; Wiley; Volume: 96; Issue: 2 Linguagem: Inglês

10.1111/j.1471-4159.2005.03573.x

1471-4159

Hong Yi, Yukihiro Akao, Wakako Maruyama, Kavin Chen, Jean C. Shih, Makoto Naoi,

Nerve injury and regeneration

Abstract Mitochondrial monoamine oxidase (MAO) has been considered to be involved in neuronal degeneration either by increased oxidative stress or protection with the inhibitors of type B MAO (MAO‐B). In this paper, the role of type A MAO (MAO‐A) in apoptosis was studied using human neuroblastoma SH‐SY5Y cells, where only MAO‐A is expressed. An endogenous dopaminergic neurotoxin, N ‐methyl( R )salsolinol, an MAO‐A inhibitor, reduced membrane potential, ΔΨm, in isolated mitochondria, and induced apoptosis in the cells, which 5‐hydroxytryptamine, an MAO‐A substrate, prevented. In contrast, β‐phenylethylamine, an MAO‐B substrate, did not suppress the ΔΨm decline by N ‐methyl( R )salsolinol. The binding of N ‐methyl( R )salsolinol to mitochondria was inhibited by clorgyline, a MOA‐A inhibitor, but not by (–)deprenyl, an MAO‐B inhibitor. RNA interference targeting MAO‐A significantly reduced the binding of N ‐methyl( R )salsolinol with simultaneous reduction in the MAO activity. To examine the intervention of MAO‐B in the apoptotic process, human MAO‐B was transfected to SH‐SY5Y cells, but the sensitivity to N ‐methyl( R )salsolinol was not affected, even although the activity and protein of MAO increased markedly. These results demonstrate a novel function of MAO‐A in the binding of neurotoxins and the induction of apoptosis, which may account for neuronal cell death in neurodegenerative disorders, including Parkinson's disease.